Aurobindo Pharma unit gets US FDA warning letter

Aurobindo Pharma unit gets US FDA warning letter — Eugia Pharma Specialities Ltd., Unit I, received a warning letter from the US FDA following an inspection. This regulatory action may impact export approvals and market perception. The stock could face near-term volatility due to compliance concerns.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #FDA